Professur für Molekulare Mechanismen der Organfibrose

Reallocation / Closing: 30.09.2022


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Revised European Scleroderma Trials and Research Group Activity Index is the best predictor of short-term severity accrual (2019) Fasano S, Riccardi A, Messiniti V, Caramaschi P, Rosato E, Maurer B, Smith V, et al. Journal article Progressive fibrosing interstitial lung disease associated with systemic autoimmune diseases (2019) Fischer A, Distler J Journal article, Review article Acyltransferase skinny hedgehog regulates TGFβ-dependent fibroblast activation in SSc (2019) Liang R, Kagwiria R, Zehender A, Dees C, Bergmann C, Krasowska D, Michalska-Jakubus M, et al. Journal article Predictors for the Development of Systemic Sclerosis Associated Interstitial Lung Disease (SSc-ILD) - Data from the German SSc-Network (2019) Kreuter M, Bonella F, Blank N, Siegert E, Henes J, Worm M, Sunderkoetter C, et al. Conference contribution Rationale for the evaluation of nintedanib as a treatment for systemic sclerosis–associated interstitial lung disease (2019) Wollin L, Distler J, Denton CP, Gahlemann M Journal article, Review article Outcomes of patients with systemic sclerosis treated with rituximab in contemporary practice: A prospective cohort study (2019) Elhai M, Boubaya M, Distler O, Smith V, Matucci-Cerinic M, Alegre Sancho JJ, Truchetet ME, et al. Journal article Response to: 'Idiopathic inflammatory myopathies and antisynthetase syndrome: Contribution of antisynthetase antibodies to improve current classification criteria' by Greco et al (2019) Knitza J, Cavagna L, Schett G, Distler J Journal article PU.1 controls fibroblast polarization and tissue fibrosis (2019) Wohlfahrt T, Rauber S, Uebe S, Luber M, Soare A, Ekici AB, Weber S, et al. Journal article The non-neuronal cyclin-dependent kinase 5 is a fibrotic mediator potentially implicated in systemic sclerosis and a novel therapeutic target (2018) Wei J, Marangoni RG, Fang F, Wang W, Huang J, Distler J, Varga J Journal article Targeting TGF-beta signaling for the treatment of fibrosis (2018) Györfi AH, Matei AE, Distler J Journal article